(-)-demecolcine increases expression EXP 6480464 Demecolcine results in increased expression of GNA15 mRNA CTD PMID:23649840 17alpha-ethynylestradiol increases expression ISO RGD:619751 6480464 Ethinyl Estradiol results in increased expression of GNA15 mRNA CTD PMID:17557909 17beta-estradiol multiple interactions ISO RGD:619751 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of GNA15 mRNA CTD PMID:26496021 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of GNA15 mRNA CTD PMID:30165855 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:619751 6480464 2 more ... CTD PMID:27291303 2,4-Nonadienal increases response to substance EXP 6480464 GNA15 protein results in increased susceptibility to 2, 4-nonadienal CTD PMID:15598656 2,4-Nonadienal multiple interactions EXP 6480464 [GNA15 protein results in increased susceptibility to 2, 4-nonadienal] which results in increased activity of OLFR43 protein CTD PMID:15598656 acetamide increases expression ISO RGD:619751 6480464 acetamide results in increased expression of GNA15 mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:619751 6480464 Acrylamide results in decreased expression of GNA15 mRNA CTD PMID:28959563 aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of GNA15 polyA tail CTD PMID:30157460 aflatoxin B2 increases methylation EXP 6480464 aflatoxin B2 results in increased methylation of GNA15 polyA tail CTD PMID:30157460 alpha-ionone increases response to substance EXP 6480464 GNA15 protein results in increased susceptibility to alpha-ionone CTD PMID:15598656 alpha-ionone multiple interactions EXP 6480464 [GNA15 protein results in increased susceptibility to alpha-ionone] which results in increased activity of OLFR43 protein CTD PMID:15598656 ammonium chloride affects expression ISO RGD:619751 6480464 Ammonium Chloride affects the expression of GNA15 mRNA CTD PMID:16483693 amphetamine increases expression ISO RGD:619751 6480464 Amphetamine results in increased expression of GNA15 mRNA CTD PMID:30779732 antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of GNA15 mRNA CTD PMID:24449571 benzo[a]pyrene decreases expression ISO RGD:732131 6480464 Benzoapyrene results in decreased expression of GNA15 mRNA CTD PMID:27195522 benzo[a]pyrene decreases methylation EXP 6480464 Benzoapyrene results in decreased methylation of GNA15 exon, Benzoapyrene results in decreased methylation of GNA15 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation EXP 6480464 Benzoapyrene affects the methylation of GNA15 3' UTR, Benzoapyrene affects the methylation of GNA15 polyA tail CTD PMID:27901495 , PMID:30157460 benzo[e]pyrene increases methylation EXP 6480464 benzoepyrene results in increased methylation of GNA15 polyA tail CTD PMID:30157460 bisphenol A multiple interactions ISO RGD:619751 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of GNA15 mRNA CTD PMID:26496021 bisphenol A decreases expression ISO RGD:619751 6480464 bisphenol A results in decreased expression of GNA15 mRNA CTD PMID:25181051 butan-1-ol multiple interactions EXP 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GNA15 mRNA CTD PMID:29432896 butanal increases expression EXP 6480464 butyraldehyde results in increased expression of GNA15 mRNA CTD PMID:26079696 C60 fullerene increases expression ISO RGD:619751 6480464 fullerene C60 results in increased expression of GNA15 mRNA CTD PMID:19167457 carvone multiple interactions ISO RGD:732131 6480464 [GNA15 protein results in increased susceptibility to carvone] which results in increased activity of OLFR50 protein CTD PMID:9875846 carvone increases response to substance ISO RGD:732131 6480464 GNA15 protein results in increased susceptibility to carvone CTD PMID:9875846 citral dimethyl acetal multiple interactions EXP 6480464 [GNA15 protein results in increased susceptibility to citral dimethyl acetal] which results in increased activity of OLFR43 protein CTD PMID:15598656 citral dimethyl acetal increases response to substance EXP 6480464 GNA15 protein results in increased susceptibility to citral dimethyl acetal CTD PMID:15598656 citronellal multiple interactions ISO RGD:732131 6480464 [GNA15 protein results in increased susceptibility to citronellal] which results in increased activity of OLFR49 protein CTD PMID:9875846 citronellal increases response to substance ISO RGD:732131 6480464 GNA15 protein results in increased susceptibility to citronellal CTD PMID:9875846 dextran sulfate multiple interactions ISO RGD:732131 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GNA15 mRNA CTD PMID:29950665 ethanol increases expression ISO RGD:619751 6480464 Ethanol results in increased expression of GNA15 mRNA CTD PMID:20655511 flavonoids increases expression ISO RGD:619751 6480464 Flavonoids results in increased expression of GNA15 mRNA CTD PMID:18035473 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of GNA15 mRNA CTD PMID:23649840 furan increases expression ISO RGD:619751 6480464 furan results in increased expression of GNA15 mRNA CTD PMID:27387713 geraniol increases response to substance EXP 6480464 GNA15 protein results in increased susceptibility to geraniol CTD PMID:15598656 geraniol multiple interactions EXP 6480464 [GNA15 protein results in increased susceptibility to geraniol] which results in increased activity of OLFR43 protein CTD PMID:15598656 heptan-2-one increases response to substance EXP 6480464 GNA15 protein results in increased susceptibility to 2-heptanone CTD PMID:15598656 heptan-2-one multiple interactions EXP 6480464 [GNA15 protein results in increased susceptibility to 2-heptanone] which results in decreased activity of OLFR154 protein CTD PMID:15598656 heptanal multiple interactions ISO RGD:732131 6480464 [GNA15 protein results in increased susceptibility to heptanal] which results in increased activity of OLFR2 protein CTD PMID:9875846 heptanal increases response to substance ISO RGD:732131 6480464 GNA15 protein results in increased susceptibility to heptanal CTD PMID:9875846 isoprenaline increases response to substance ISO RGD:732131 6480464 GNA15 protein results in increased susceptibility to Isoproterenol CTD PMID:9875846 isoprenaline multiple interactions ISO RGD:732131 6480464 [GNA15 protein results in increased susceptibility to Isoproterenol] which results in increased activity of ADRB2 protein CTD PMID:9875846 limonene multiple interactions ISO RGD:732131 6480464 [GNA15 protein results in increased susceptibility to limonene] which results in increased activity of OLFR56 protein CTD PMID:9875846 limonene increases response to substance ISO RGD:732131 6480464 GNA15 protein results in increased susceptibility to limonene CTD PMID:9875846 methapyrilene increases methylation EXP 6480464 Methapyrilene results in increased methylation of GNA15 polyA tail CTD PMID:30157460 methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of GNA15 mRNA CTD PMID:23649840 nickel atom increases expression EXP 6480464 Nickel results in increased expression of GNA15 mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of GNA15 mRNA CTD PMID:22714537 nonanedioic acid multiple interactions EXP 6480464 [GNA15 protein results in increased susceptibility to azelaic acid] which results in increased activity of OLFR544 protein CTD PMID:15598656 nonanedioic acid increases response to substance EXP 6480464 GNA15 protein results in increased susceptibility to azelaic acid CTD PMID:15598656 nonanoic acid increases response to substance EXP 6480464 GNA15 protein results in increased susceptibility to pelargonic acid CTD PMID:15598656 nonanoic acid multiple interactions EXP 6480464 [GNA15 protein results in increased susceptibility to pelargonic acid] which results in increased activity of OLFR586 protein CTD PMID:15598656 octanal multiple interactions ISO RGD:619751 6480464 [GNA15 protein results in increased susceptibility to caprylic aldehyde] which results in increased activity of OLR226 protein CTD PMID:9875846 octanal multiple interactions EXP 6480464 [GNA15 protein results in increased susceptibility to caprylic aldehyde] which results in increased activity of OLFR43 protein CTD PMID:15598656 octanal increases response to substance ISO RGD:619751 6480464 GNA15 protein results in increased susceptibility to caprylic aldehyde CTD PMID:9875846 octanal increases response to substance EXP 6480464 GNA15 protein results in increased susceptibility to caprylic aldehyde CTD PMID:15598656 octanoic acid multiple interactions EXP 6480464 [GNA15 protein results in increased susceptibility to octanoic acid] which results in increased activity of OLFR544 protein, [GNA15 protein results in increased susceptibility to octanoic acid] which results in increased activity of OLFR586 protein CTD PMID:15598656 octanoic acid increases response to substance EXP 6480464 GNA15 protein results in increased susceptibility to octanoic acid CTD PMID:15598656 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of GNA15 mRNA CTD PMID:26690555 quercetin increases expression EXP 6480464 Quercetin results in increased expression of GNA15 mRNA CTD PMID:15309432 silicon dioxide increases expression ISO RGD:732131 6480464 Silicon Dioxide results in increased expression of GNA15 mRNA CTD PMID:29341224 Soman increases expression ISO RGD:619751 6480464 Soman results in increased expression of GNA15 mRNA CTD PMID:19281266 titanium dioxide decreases expression ISO RGD:732131 6480464 titanium dioxide results in decreased expression of GNA15 mRNA CTD PMID:29264374 titanium dioxide multiple interactions ISO RGD:732131 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GNA15 mRNA CTD PMID:29950665 valproic acid increases methylation EXP 6480464 Valproic Acid results in increased methylation of GNA15 gene CTD PMID:29154799 vincristine increases expression EXP 6480464 Vincristine results in increased expression of GNA15 mRNA CTD PMID:23649840